Darolutamide Plus ADT Elicits OS Benefit in North American Patients With mHSPC
OncLive,
A subgroup analysis of the phase 3 ARASENS trial showed that darolutamide plus androgen deprivation therapy elicited an overall…
MP29-02 EFFICACY AND SAFETY OF DAROLUTAMIDE IN COMBINATION WITH ANDROGEN-DEPRIVATION THERAPY AND DOCETAXEL IN THE NORTH AMERICAN POPULATION FROM ARASENS
Overview of attention for article published in The Journal of Urology, April 2023
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (76th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)
Readers on
- mendeley
- 4 Mendeley